制药(BK4007)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

BK4007 制药

未开盘 05-19 16:00:00 EDT

846.29

+12.36

+1.48%

最高849.02	最低832.21	成交量3.59亿
今开834.10	昨收833.93	日振幅2.02%
总市值0.00	流通市值0.00	总股本0.00
成交额129.67亿	换手率--	流通股本0.00
市净率5.166201	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"BK4007","market":"US","secType":"PLATE","nameCN":"制药","latestPrice":846.2861,"timestamp":1779220799999,"preClose":833.9293,"halted":0,"volume":358662862,"delay":0,"changeRate":0.014818,"floatShares":0,"shares":0,"eps":0,"marketStatus":"未开盘","change":12.35675,"latestTime":"05-19 16:00:00 EDT","open":834.09534,"high":849.0242,"low":832.2108,"amount":12966756900.09368,"amplitude":0.020162,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1779264000000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":5.166201,"peRate":26.076785,"increases":0,"decrements":0,"flats":0},"requestUrl":"/m/hq/s/BK4007/tweets","defaultTab":"tweets","newsList":[{"id":"2636860335","title":"Catcher Predict：“Dota 2：Natus Vincere 对阵 Aurora（BO3）- DreamLeague 季后赛” “两队都击败 Roshan” 胜率飙升 40%","url":"https://stock-news.laohu8.com/highlight/detail?id=2636860335","media":"链捕手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636860335?lang=zh_cn&edition=full","pubTime":"2026-05-20 06:00","pubTimestamp":1779228016,"startTime":"0","endTime":"0","summary":" 据 Catcher Predict 监测，预测市场 Polymarket 上“Dota 2：Natus Vincere 对阵 Aurora（BO3）- DreamLeague 季后赛”事件中，子市场“两队都击败 Roshan”的“是”选项胜率发生剧烈波动，由 1 小时前的 50% 飙升至当前的 90%（波动幅度达 40%）。请注意相关突发消息影响。 ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.chaincatcher.com/article/2265877","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ACB","BK4557","MSOS","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636548867","title":"纳斯达克金龙中国指数收跌0.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2636548867","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636548867?lang=zh_cn&edition=full","pubTime":"2026-05-20 05:04","pubTimestamp":1779224675,"startTime":"0","endTime":"0","summary":"纳斯达克金龙中国指数收跌0.01%，报6790.30点。麦思智能涨超7%，奇景光电涨超6%，慧荣科技、贝壳涨超5%，中华电信涨超3%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202605203742439654.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202605203742439654.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["NJAN","QQQM","QQQX","07522","NDX","BK4007","NJUL","03455","QYLG","QQQJ","NAPR","09086","QID","MNQmain","IYW","02834","QDEC","JEPQ","QQQE","QDTE","TECS","07261","07568","QQQA","HXC","TQQY","ONEQ","QLD","07266","PSQ","QMAR","03034","SQQQ","GPIQ",".IXIC","09834","NOCT","QQQ","QQQY","TQQQ","FTEC","BK1147","NQmain","NVIW.SI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1169454238","title":"Eton Pharmaceuticals Inc 获Impavido美国独家商业化权利 自2026年9月26日起生效","url":"https://stock-news.laohu8.com/highlight/detail?id=1169454238","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1169454238?lang=zh_cn&edition=full","pubTime":"2026-05-20 04:31","pubTimestamp":1779222693,"startTime":"0","endTime":"0","summary":"Eton Pharmaceuticals Inc 宣布获得Impavido在美国市场的独家商业化权利，该授权将于2026年9月26日正式生效。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ETON","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1107071325","title":"伊顿制药通过获取英帕维多®美国商业化权益协议，拓展罕见病产品组合","url":"https://stock-news.laohu8.com/highlight/detail?id=1107071325","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1107071325?lang=zh_cn&edition=full","pubTime":"2026-05-20 04:30","pubTimestamp":1779222611,"startTime":"0","endTime":"0","summary":"伊顿制药公司宣布，已签署一项协议，获得英帕维多®（米替福新）在美国的商业化权利。此举标志着该公司在其罕见病治疗领域的产品组合得到了进一步扩展。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ETON"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1110203987","title":"美国食品药品监督管理局授予Dectomax/Dectomax-CA1（多拉菌素注射液）紧急使用授权","url":"https://stock-news.laohu8.com/highlight/detail?id=1110203987","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1110203987?lang=zh_cn&edition=full","pubTime":"2026-05-19 23:38","pubTimestamp":1779205101,"startTime":"0","endTime":"0","summary":"美国食品药品监督管理局（FDA）已正式授予Dectomax及Dectomax-CA1（多拉菌素注射液）这一可注射溶液的紧急使用授权（EUA）。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ZTS","LU2023251221.USD","LU1059921491.USD","LU2089283258.USD","LU0471298694.HKD","LU2271345857.HKD","LU0107464264.USD","LU1721429402.USD","LU0058720904.USD","LU1941712348.USD","LU2308191902.HKD","LU0471298777.SGD","LU2028103732.USD","GB00BDT5M118.USD","BK4585","LU0289739699.SGD","LU0385154629.USD","LU2089284900.SGD","BK4007","LU0345774631.USD","BK4588","BK4534","LU1721429741.USD","LU0158827781.USD","LU1236620750.USD","LU0079474960.USD","LU0345774391.USD","IE00B19Z9505.USD","LU2111349929.HKD","LU2360106947.USD","LU1236620834.HKD","LU0158827948.USD","LU1941712264.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636854774","title":"Polymarket 与纳斯达克合作，推出针对非上市公司的预测市场","url":"https://stock-news.laohu8.com/highlight/detail?id=2636854774","media":"链捕手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636854774?lang=zh_cn&edition=full","pubTime":"2026-05-19 21:55","pubTimestamp":1779198936,"startTime":"0","endTime":"0","summary":" ChainCatcher 消息，据路透社报道，Polymarket 与纳斯达克合作，推出针对非上市公司的预测市场，用户可根据估值、IPO 时间以及二级市场估值进行交易。 ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.chaincatcher.com/article/2265824","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09086","IYW","QQQM","FTEC","TQQY","BK1147","QQQA","NOCT","NJAN","07266","MNQmain","QDEC","TECS","07522","SQQQ","QQQJ","NVIW.SI","NJUL","03455","QMAR","GPIQ","QID","TQQQ","09834","NDAQ","ONEQ","QQQX","QQQ","BK4007","QYLG","07261","07568","JEPQ","02834","QDTE","QQQE","NAPR","QQQY","QLD","03034","PSQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636285450","title":"道琼斯指数开盘下跌 259.31 点，标普500 和纳斯达克均下跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2636285450","media":"链捕手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636285450?lang=zh_cn&edition=full","pubTime":"2026-05-19 21:32","pubTimestamp":1779197565,"startTime":"0","endTime":"0","summary":" ChainCatcher 消息，据 Gate 行情数据显示，道琼斯指数在 5 月 19 日（周二）开盘下跌 259.31 点，跌幅 0.52%，报 49,426.81 点；标普500 指数开盘下跌 38.05 点，跌幅 0.51%，报 7,365 点；纳斯达克综合指数开盘下跌 155.09 点，跌幅 0.59%，报 25,935.64 点。 ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.chaincatcher.com/article/2265820","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["QQQY","03034","SVIX","TQQY","VEU","QDEC","SPXS","SPYH","BK4007","DGRO","SDS","SPLV","DMAX","YMAX","SPHD","XYLD","ETFT","FDVV","BK4585","QID","HXC","SQQQ","SH","IJH","QDTE","JEPI","SPMO","RSPU","03455","QLD","GPIX","SPUS","SSO","BK1147","HIBL","02834","BK4581","SPUU","TECS","VIXY","NOBL","ACWI","JEPQ","QQQX","VTI","QQQJ","DJX","DVY","SPDN","BK4550","QQQ","SPYD","MESmain","SDOW","RSPN","SPGP","SPYM","XLG","IYW","TSPY","IJR","SDY","SPYU","UVIX","YSPY","DBSC","QMAR","SMAX","SPYI","NDX","QQQA","09086","UDOW","IVW","VVIX",".SPX","TQQQ","TVIXF","VXZ","OEF","QQQE","DDM","SFY","DJIA","07266","TOPT","VBK","MMAX","BK4588",".IXIC",".DJI","IVV","ALLW","USMV","NVIW.SI","UPRO","VYMI","MNQmain","SVXY","XDTE","GRNY","FDN","FTEC","SPYQ","VXX","GSLC","QQQM","NJUL","ITOT","SCHX","07261","VYLD","07522","SPYV","BK4504","NJAN","VXMmain","SPYB","SPXU","BMAY","OEX","ONEQ","RSPA","VTV","DGRW","MOAT","RSP","SPHQ","XLI","PSQ","HIBS","UVXY","NOCT","SCHB","GPIQ","BK4559","VV","09834","SVOL","VIXM","VIXmain","SPXL","NAPR","QYLG","DXD","SPYG","DOG","BK4534","07568","MGK","IVE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1100827537","title":"Hoth Therapeutics 计划持续推进生物技术项目，或考虑将资产注入独立子公司","url":"https://stock-news.laohu8.com/highlight/detail?id=1100827537","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1100827537?lang=zh_cn&edition=full","pubTime":"2026-05-19 20:22","pubTimestamp":1779193338,"startTime":"0","endTime":"0","summary":"Hoth Therapeutics 宣布，公司将继续推进其生物技术项目。同时，公司正考虑将部分资产置于一个独立的子公司中。这一举措旨在优化资产结构，可能为特定项目或技术平台的未来发展提供更清晰的战略聚焦和运营灵活性。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HOTH","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1192836313","title":"交易完成后，InMed Pharmaceuticals合并公司备考股权价值约4.214亿美元（含私募配售）","url":"https://stock-news.laohu8.com/highlight/detail?id=1192836313","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1192836313?lang=zh_cn&edition=full","pubTime":"2026-05-19 20:09","pubTimestamp":1779192550,"startTime":"0","endTime":"0","summary":"根据最新披露，InMed Pharmaceuticals Inc（InMed Pharmaceuticals Inc）在完成相关交易后，合并公司的备考股权价值预计将达到约4.214亿美元。这一估值已将同时进行的私募配售所得资金纳入计算。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INM","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1117049943","title":"InMed Pharmaceuticals：合并后公司股权结构揭晓，原股东预计持股约1.51%","url":"https://stock-news.laohu8.com/highlight/detail?id=1117049943","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1117049943?lang=zh_cn&edition=full","pubTime":"2026-05-19 20:02","pubTimestamp":1779192156,"startTime":"0","endTime":"0","summary":"InMed Pharmaceuticals Inc（InMed Pharmaceuticals）的股东们，在即将到来的企业合并中，预计将持有合并后新公司大约1.51%的股份。这一股权比例，勾勒出交易完成后公司所有权结构的关键轮廓。随着整合进程的推进，股东权益的重新分配成为市场关注的焦点。最终的股权构成，将对公司的未来治理与发展方向产生深远影响。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","INM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1152538362","title":"Enveric Biosciences 公布其先导神经塑原候选药物 EB-003 光毒性分析取得积极临床前结果","url":"https://stock-news.laohu8.com/highlight/detail?id=1152538362","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1152538362?lang=zh_cn&edition=full","pubTime":"2026-05-19 20:01","pubTimestamp":1779192107,"startTime":"0","endTime":"0","summary":"Enveric Biosciences 近日宣布，其在研的先导神经塑原候选药物 EB-003 的光毒性分析取得了积极的临床前研究结果。该分析旨在评估药物在光照条件下对皮肤的潜在毒性影响，是药物开发中安全性评价的关键环节。初步数据显示，EB-003 在此项分析中表现出良好的安全性特征，未引发显著的光毒性反应。这一积极结果为该候选药物的后续临床开发路径提供了重要的支持数据，增强了其作为潜在治疗方案的可行性。公司表示，将继续推进 EB-003 的临床前研究，为未来进入临床试验阶段奠定基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ENVB","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1187912495","title":"Enveric Biosciences公司宣布其EB-003成为首个选择性靶向5-HT2A与5-HT1B受体的已知化合物","url":"https://stock-news.laohu8.com/highlight/detail?id=1187912495","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1187912495?lang=zh_cn&edition=full","pubTime":"2026-05-19 20:01","pubTimestamp":1779192085,"startTime":"0","endTime":"0","summary":"Enveric Biosciences公司披露，其候选药物EB-003已成为首个已知能选择性同时作用于5-HT2A和5-HT1B受体的化合物。这一发现标志着该公司在神经精神疾病治疗领域的研发取得了重要进展。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ENVB","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1140623873","title":"世卫组织驻刚果代表：默沙东Ervebo是潜在可预防埃博拉病毒的疫苗之一","url":"https://stock-news.laohu8.com/highlight/detail?id=1140623873","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1140623873?lang=zh_cn&edition=full","pubTime":"2026-05-19 17:58","pubTimestamp":1779184699,"startTime":"0","endTime":"0","summary":"世界卫生组织驻刚果（金）代表指出，默沙东公司研发的Ervebo疫苗，属于有望为埃博拉病毒提供预防与保护的潜在候选疫苗之一。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BJJMRZ35.SGD","LU1066051811.HKD","LU2112291526.USD","LU0942090050.USD","LU0070302665.USD","LU1934455194.USD","LU2106854487.HKD","LU2491049909.HKD","SG9999013999.USD","LU1037948897.HKD","LU0266013472.USD","LU1057294990.SGD","IE00B1BXHZ80.USD","LU1974910355.USD","LU1066053197.SGD","LU1699723380.USD","BK4559","LU0868494708.USD","LU1941712264.USD","IE00BLSP4239.USD","LU1934455863.HKD","SG9999001440.SGD","LU2360032135.SGD","LU1037948541.HKD","IE00BFTCPJ56.SGD","LU0208291251.USD","LU1069347547.HKD","IE00BSNM7G36.USD","LU1934455277.USD","LU2491050071.SGD","BK4534","LU0965508806.USD","LU1989772840.SGD","LU0861579265.USD","MRK","SG9999015358.SGD","SG9999014575.USD","LU1989772923.USD","LU0058720904.USD","LU0980610538.SGD","BK4516","SG9999014542.SGD","IE000M9KFDE8.USD","LU1983299246.USD","LU1035773651.USD","LU0211331839.USD","LU0130102774.USD","BK4588","LU1571399168.USD","BK4550","LU1116320901.HKD","LU1093756325.SGD","IE00BLSP4452.SGD","BK4533","LU2125909593.SGD","LU1917777945.USD","LU0203347892.USD","LU0432979614.USD","IE0002141913.USD","IE00BBT3K403.USD","LU1066051225.USD","LU0320765646.SGD","LU1061106388.HKD","LU2361044949.HKD","LU0238689110.USD","LU0965509101.SGD","LU2125154935.USD","LU0648001328.SGD","LU2023250843.SGD","SG9999014567.USD","LU1989771016.USD","BK4007","SG9999001176.USD","LU1023059063.AUD","LU1923622614.USD","IE00B4R5TH58.HKD","LU0098860793.USD","LU0265550359.USD","LU0868494617.USD","LU1585245621.USD","LU2361044865.SGD","IE00BJT1NW94.SGD","LU1929549753.HKD","SG9999002232.USD","LU2023250504.SGD","LU0130517989.USD","LU1066051498.USD","SG9999014559.SGD","LU2125154778.USD","SGXZ57979304.SGD","LU0265550946.USD","LU1941712348.USD","LU0203345920.USD","LU0859254822.USD","LU2461242641.AUD","LU2089984988.USD","LU2468319806.SGD","LU0122379950.USD","IE00B2B36J28.USD","LU0289739699.SGD","SG9999001176.SGD","LU1291159041.SGD","LU1201861249.SGD","LU1162221912.USD","LU0477156953.USD","SG9999015341.SGD","LU0320765489.SGD","IE00BN8TJ469.HKD","LU0965509283.SGD","BK4585","LU2433249047.HKD","LU0965509010.AUD","LU0106261372.USD","LU1093756168.USD","LU2361045086.USD","SG9999002224.SGD","LU0234572021.USD","LU0006306889.USD","LU1116320737.USD","LU2491050154.USD","LU1430594728.SGD","IE0009355771.USD","LU2324357040.USD","LU2357627491.SGD","LU2125909247.SGD","LU0985320562.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636836985","title":"拜耳(BAYRY)新药获FDA优先审评 聚焦二次中风预防","url":"https://stock-news.laohu8.com/highlight/detail?id=2636836985","media":"金吾财讯","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636836985?lang=zh_cn&edition=full","pubTime":"2026-05-19 16:10","pubTimestamp":1779178215,"startTime":"0","endTime":"0","summary":"值得注意的是，asundexian 在 2023 年已获得 FDA 快速通道资格，此次优先审评资格的授予，进一步凸显了该药物在二次中风预防领域的潜在价值。FDA 的优先审评资格，主要授予那些获批后能显著提升严重疾病治疗、预防或诊断安全性与有效性的药物。","market":"fut","thumbnail":"https://static.szfiu.com/news/20250107/NjEzNTY0MzU5MDE2.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250107/NjEzNTY0MzU5MDE2.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"300574","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BAYRY","BK4007","BK4585","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636356678","title":"重磅ADC药物获批多发性骨髓瘤二线联合用药，GSK中国特药业务部负责人：肿瘤是未来GSK重要增长引擎之一","url":"https://stock-news.laohu8.com/highlight/detail?id=2636356678","media":"蓝鲸财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636356678?lang=zh_cn&edition=full","pubTime":"2026-05-19 15:41","pubTimestamp":1779176518,"startTime":"0","endTime":"0","summary":"值得注意的是，倍乐锐是GSK肿瘤领域的重磅药物。据GSK全球一季度财报，该药物在今年一季度收入达2300万英镑，在该款药物的加持下，肿瘤业务也已经是GSK当前业绩增长最快的板块。今年第一季度，GSK肿瘤业务销售额同比增长28%，达到5.12亿英镑，业务增速在所有业务中位居第一。GSK副总裁、中国特药业务部负责人张宁向蓝鲸新闻表示，GSK未来会考虑布局更多的ADC药物、小分子药物等形成合力，包括肿瘤在内的特药业务是未来GSK很重要的增长引擎之一。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1779176429659930072","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["BK4231","LU1829250122.USD","GSK.UK","GSKH","ADC","BK4532","GSK","BK4588","BK4080","BK4007","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636388663","title":"福建：到2030年全省光电产业集群营收规模超3000亿元 加快推动高速光模块研发","url":"https://stock-news.laohu8.com/highlight/detail?id=2636388663","media":"格隆汇APP","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636388663?lang=zh_cn&edition=full","pubTime":"2026-05-19 10:18","pubTimestamp":1779157080,"startTime":"0","endTime":"0","summary":"格隆汇5月19日｜近日，《福建省“十五五”光电产业集群高质量发展行动方案》公开征求意见。其中提到，到2030年，全省光电产业集群营收规模超3000亿元，初步建成链条完整、生态完善、具有国际影响力的光电产业集群。支持优势企业拓展海洋光缆、高性能光缆等特色细分领域，持续完善提升光电产业链条。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/bxjj/2026-05-19/doc-inhykxft7559532.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4161","LU0566484027.USD","IE0034390439.USD","BK4007","LU1559883803.SGD","NPO","IE00B19Z6F94.USD","LU2065732104.USD","OCS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636788370","title":"港股异动 | 科伦博泰生物(06990)早盘涨超5% 默沙东TROP2靶向ADC疗法3期临床成功","url":"https://stock-news.laohu8.com/highlight/detail?id=2636788370","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636788370?lang=zh_cn&edition=full","pubTime":"2026-05-19 09:36","pubTimestamp":1779154588,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，科伦博泰生物(06990)早盘涨超5%，截至发稿，涨4.71%，报444.2港元，成交额3844.07万港元。消息面上，默沙东宣布，其从科伦博泰引进的在研TROP2抗体偶联药物芦康沙妥珠单抗（sac‑TMT）用于特定晚期或复发性子宫内膜癌患者的III期TroFuse‑005研究已成功达到总生存期（OS）与无进展生存期（PFS）两项主要终点，并在关键次要终点客观缓解率（ORR）上同样取得积极结果。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1443249.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"港股异动 | 科伦博泰生物(06990)早盘涨超5% 默沙东TROP2靶向ADC疗法3期临床成功","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1066051225.USD","SG9999001440.SGD","LU0965509101.SGD","LU0058720904.USD","SG9999014559.SGD","SG9999015358.SGD","SG9999015341.SGD","LU1934455277.USD","BK4534","LU2361044949.HKD","SG9999014542.SGD","IE00B4R5TH58.HKD","LU2433249047.HKD","LU0985320562.USD","SG9999014567.USD","BK4516","LU0320765489.SGD","BK4533","LU0208291251.USD","LU2106854487.HKD","LU0868494617.USD","LU0965509010.AUD","BK4559","LU1037948897.HKD","SG9999001176.SGD","LU2023250504.SGD","BK1161","LU1585245621.USD","LU1069347547.HKD","LU1291159041.SGD","LU0203345920.USD","IE0002141913.USD","SG9999013999.USD","LU2324357040.USD","LU1934455194.USD","LU0868494708.USD","SGXZ57979304.SGD","LU1116320901.HKD","LU1989772923.USD","LU1571399168.USD","LU2125909247.SGD","BK4550","LU0211331839.USD","LU2125909593.SGD","LU0106261372.USD","LU1066051498.USD","LU0861579265.USD","LU2491050071.SGD","LU1941712348.USD","LU1923622614.USD","SG9999001176.USD","LU0432979614.USD","LU1941712264.USD","IE00BLSP4452.SGD","IE0009355771.USD","IE00BN8TJ469.HKD","LU1201861249.SGD","LU1974910355.USD","LU2361044865.SGD","LU1162221912.USD","BK4080","LU1093756168.USD","IE00B2B36J28.USD","LU2491050154.USD","SG9999014575.USD","LU0006306889.USD","LU0203347892.USD","LU1989771016.USD","LU1035773651.USD","LU1934455863.HKD","LU2023250843.SGD","LU2360032135.SGD","IE00BFTCPJ56.SGD","LU0234572021.USD","LU0289739699.SGD","LU1917777945.USD","LU1037948541.HKD","LU1699723380.USD","SG9999002232.USD","BK4585","LU0477156953.USD","IE00BJJMRZ35.SGD","LU0265550359.USD","LU0320765646.SGD","LU1066053197.SGD","LU0965509283.SGD","LU0238689110.USD","IE00B1BXHZ80.USD","LU0648001328.SGD","LU1057294990.SGD","IE00BLSP4239.USD","BK4588","IE000M9KFDE8.USD","LU0196878994.USD","LU1061106388.HKD","LU2461242641.AUD","LU1929549753.HKD","LU1066051811.HKD","LU0942090050.USD","LU0965508806.USD","LU2125154935.USD","LU1983299246.USD","LU1989772840.SGD","IE00BBT3K403.USD","IE00BSNM7G36.USD","LU2491049909.HKD","LU0098860793.USD","06990","LU1093756325.SGD","LU2125154778.USD","LU1430594728.SGD","SG9999002224.SGD","IE00BJT1NW94.SGD","LU0130102774.USD","LU2089984988.USD","LU0980610538.SGD","LU1023059063.AUD","LU0070302665.USD","LU0122379950.USD","BK4231","LU0265550946.USD","LU0859254822.USD","BK4007","LU2361045086.USD","LU0266013472.USD","LU2357627491.SGD","LU1116320737.USD","LU2112291526.USD","LU2468319806.SGD","LU0130517989.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636700080","title":"广药接手达安基因；阿斯利康高血压创新药获美国FDA批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2636700080","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636700080?lang=zh_cn&edition=full","pubTime":"2026-05-19 08:01","pubTimestamp":1779148914,"startTime":"0","endTime":"0","summary":"政策动向2026年医保目录调整新增预申报允许商保创新药申报医保目录国家医保局介绍2026年国家医保药品目录及商业健康保险创新药品目录调整工作安排，包括首次允许纳入2025年商保创新药目录的药品申报国家医保目录，新增“预申报”环节等。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202605193741160824.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202605193741160824.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK0046","LU1829250122.USD","BK0028","BK0168","LU0889565916.HKD","LU0058720904.USD","BK1161","06978","BK4588","BK4585","LU2237443978.SGD","BK1574","LABU","159992","002030","LU2237443465.HKD","LU2237443549.SGD","AZNH","LU2237443895.HKD","BK0188","LU2237443382.USD","LU2417539215.USD","BK4568","BK0159","LU0320765992.SGD","BK0042","LU2456880835.USD","LU0289739699.SGD","LU2236285917.USD","BK4007","LU0109394709.USD","BK0122","BK0239","LU2462157665.USD","LU2237443622.USD","AZN","IE00B3T34201.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1175825864","title":"Wave Life Sciences旗下WVE-006展现良好安全性，未出现严重肝毒性","url":"https://stock-news.laohu8.com/highlight/detail?id=1175825864","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1175825864?lang=zh_cn&edition=full","pubTime":"2026-05-19 04:57","pubTimestamp":1779137846,"startTime":"0","endTime":"0","summary":"Wave Life Sciences Ltd. 宣布，其研发项目WVE-006在临床试验中表现出令人鼓舞的安全性特征。数据显示，该药物未引发严重的肝脏毒性事件。这一结果对于该药物的后续开发至关重要，为评估其在目标适应症中的治疗潜力提供了积极的安全基础。公司将继续推进相关研究，以进一步评估其疗效与长期安全性。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["WVE","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1111952486","title":"Kiora制药公司提交售股股东转售至多1180万股招股说明书 - 美国证券交易委员会备案","url":"https://stock-news.laohu8.com/highlight/detail?id=1111952486","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1111952486?lang=zh_cn&edition=full","pubTime":"2026-05-19 04:35","pubTimestamp":1779136532,"startTime":"0","endTime":"0","summary":"Kiora制药公司已向美国证券交易委员会提交文件，为其售股股东转售最多1180万股公司股票进行备案。\n该招股说明书旨在为现有股东出售其持有的股份提供正式渠道，涉及转售的股份数量上限为1180万股。此举通常意味着部分早期投资者或内部人士可能计划减持其持股。\n通过向美国证券交易委员会提交此类文件，公司为特定股东的大宗股票销售建立了合规框架，确保交易过程符合监管要求。此类备案通常会引起市场对潜在股票供应增加的关注，并可能影响该股的短期交易动态。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","KPRX"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"compareEarnings":[{"period":"1week","weight":-0.006},{"period":"1month","weight":0.0332},{"period":"3month","weight":0.0691},{"period":"6month","weight":0.1244},{"period":"1year","weight":0.2335},{"period":"ytd","weight":0.076}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"name":"制药","nameEN":"BK4007"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"制药(BK4007)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供制药(BK4007)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"制药,BK4007,制药股票,制药股票老虎,制药股票老虎国际,制药行情,制药股票行情,制药股价,制药股市,制药股票价格,制药股票交易,制药股票购买,制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"制药(BK4007)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供制药(BK4007)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}